Bilateral Artificial Iris implantation in patients with bilateral iris defects.
Aniridia
Open globe injury
Reconstructive surgery
Surgical iris reconstruction
Trauma
Journal
American journal of ophthalmology case reports
ISSN: 2451-9936
Titre abrégé: Am J Ophthalmol Case Rep
Pays: United States
ID NLM: 101679941
Informations de publication
Date de publication:
Jun 2021
Jun 2021
Historique:
received:
01
12
2020
revised:
02
02
2021
accepted:
04
04
2021
entrez:
24
5
2021
pubmed:
25
5
2021
medline:
25
5
2021
Statut:
epublish
Résumé
Binocular traumatic or atraumatic iris defects can lead to an increased sensitivity to glare and cosmetic disfigurement. Surgical iris reconstruction is one approach to alleviate these problems. We report the clinical outcomes after medically indicated bilateral implantation of an Artificial Iris prosthesis in three patients with binocular iris defects with different etiologies. All three patients underwent binocular CUSTOMFLEX ArtificialIris (AI) (HumanOptics AG, Erlangen, Germany) implantation with simultaneous cataract surgery. Corrected distance visual acuity (CDVA), manifest refraction, Contrast sensitivity, endothelial cell density and subjective visual impairment as well as subjective cosmetic disfigurement were measured pre- and postoperatively. CDVA remained stable or improved in all three patients. We observed an increase in contrast sensitivity and reduction of glare sensitivity in two patients. All patients reported satisfaction with the cosmetical result after the implantation. The bilateral Artificial Iris implantation is an effective therapeutic option to reduce glare sensitivity and to achieve an aesthetically pleasing result also in selected patients with binocular traumatic or atraumatic iris defects.
Identifiants
pubmed: 34027229
doi: 10.1016/j.ajoc.2021.101108
pii: S2451-9936(21)00117-1
pmc: PMC8121880
doi:
Types de publication
Case Reports
Langues
eng
Pagination
101108Informations de copyright
© 2021 The Authors.
Déclaration de conflit d'intérêts
CM received travel grants and lecture fees from HumanOptics. The following authors have no financial disclosures: IDB, JS, RK.
Références
Graefes Arch Clin Exp Ophthalmol. 2016 Jul;254(7):1419-24
pubmed: 26892143
Surv Ophthalmol. 1977 Jan-Feb;21(4):347-50
pubmed: 835081
Br J Ophthalmol. 2016 Aug;100(8):1098-101
pubmed: 26719491
Ophthalmologica. 2018;240(3):129-134
pubmed: 30036875
Am J Ophthalmol Case Rep. 2020 Aug 20;20:100890
pubmed: 32944673
J Am Optom Assoc. 1993 Mar;64(3):176-80
pubmed: 8454834
Can J Ophthalmol. 2018 Feb;53(1):e24-e27
pubmed: 29426455
J Ophthalmol. 2018 Sep 23;2018:3262068
pubmed: 30345111
Clin Ophthalmol. 2020 Dec 21;14:4439-4450
pubmed: 33376298
Cornea. 2011 Oct;30(10):1135-9
pubmed: 21912235
Ophthalmology. 2016 May;123(5):1011-8
pubmed: 26935356
Br J Ophthalmol. 2012 Mar;96(3):464-5
pubmed: 22121161
Br J Ophthalmol. 2011 Oct;95(10):1397-401
pubmed: 21795285
Eur J Ophthalmol. 2021 Jan 28;:1120672121991052
pubmed: 33508973
J Cataract Refract Surg. 2017 Jun;43(6):724-731
pubmed: 28732604
Arch Ophthalmol. 2012 Jun;130(6):771-5
pubmed: 22801839
Ophthalmologe. 2011 Aug;108(8):710-3
pubmed: 21818665
Acta Ophthalmol. 2016 May;94(3):301-6
pubmed: 26805757
Curr Opin Ophthalmol. 2019 Jan;30(1):56-62
pubmed: 30489361
Clin Ophthalmol. 2021 Feb 24;15:799-805
pubmed: 33658755
Optom Vis Sci. 2015 Apr;92(4 Suppl 1):S36-9
pubmed: 25738840
Am J Ophthalmol. 2019 Mar;199:159-166
pubmed: 30236771
Klin Monbl Augenheilkd. 2021 Feb 19;:
pubmed: 33607679
BMC Ophthalmol. 2020 Sep 15;20(1):370
pubmed: 32933506
Mil Med. 2018 Sep 1;183(9-10):e427-e433
pubmed: 29425312
PLoS One. 2020 Aug 13;15(8):e0237616
pubmed: 32790803
J Refract Surg. 2019 Sep 1;35(9):551-558
pubmed: 31498412
Ophthalmologe. 2021 Mar 29;:
pubmed: 33779827
J Cataract Refract Surg. 2014 Mar;40(3):376-82
pubmed: 24581771